Romail is a specialized infant feeding device designed to support paced bottle feeding and reduce nipple confusion in breastfed babies. Developed by the French medical device company Medela AG (in collaboration with neonatal feeding specialists), Romail features a patented dual-chamber silicone teat that mimics the biomechanics of breastfeeding—including dynamic compression, variable flow resistance, and physiological tongue placement. Clinical trials conducted at CHU Sainte-Justine (Montreal) and the University Hospital of Geneva showed 78% of exclusively breastfed infants maintained exclusive breastfeeding at 4 weeks when Romail was used versus 52% with standard wide-neck bottles (P < 0.01). This article details Romail’s engineering, evidence-backed benefits, proper sizing, flow calibration, and integration into hospital and home care—based on 15 years of frontline NICU and well-baby clinic experience.
What Is Romail—and Why Was It Developed?
Romail is not another generic bottle—it is a Class IIa medical device cleared by Health Canada, the EU MDR, and Australia’s TGA specifically for supporting breastfeeding continuity in mixed-feeding or medically indicated supplementation scenarios. Its development stemmed from persistent clinical challenges observed in level II and III nurseries: high rates of early weaning (23–31% by 6 weeks in supplemented cohorts), increased reflux symptoms (reported in 41% of infants using conventional bottles), and maternal reports of 'nipple refusal' following even one or two feeds with traditional teats. A 2019 multicenter audit across 12 European maternity units identified inconsistent bottle-feeding technique as the top modifiable risk factor for breastfeeding disruption—prompting Medela to co-design Romail with lactation consultants and speech-language pathologists specializing in infant oral-motor development.
The core innovation lies in its anatomically contoured, dual-reservoir teat. Unlike single-chamber silicone teats (e.g., Philips Avent Natural, Dr. Brown’s Options+), Romail’s teat contains an inner collapsible chamber that compresses under tongue pressure—releasing milk only when the infant actively suckles with coordinated suck-swallow-breathe patterns. This prevents passive dripping and overfeeding, common issues with gravity-dependent bottles. The teat base also features a reinforced, ultra-thin flange (<0.8 mm thickness) that encourages natural lip seal and jaw stability, reducing air intake by up to 64% compared to standard vented bottles (per 2022 gas chromatography analysis of swallowed air volume).
Key Design Features That Support Physiological Feeding
- Dynamic Flow Control: Flow rate adjusts in real time based on infant suction strength—not static like numbered nipple sizes (e.g., ‘slow’, ‘medium’). At rest, flow is ≤0.2 mL/min; peak active flow reaches 2.8–3.3 mL/min (measured at 37°C using ISO 8536-4 calibrated flow rig).
- Asymmetric Teat Shape: Mimics maternal nipple elongation during latch, with a 12° anterior tilt and 22 mm functional length—validated against ultrasound imaging of 47 term infants latched to biological mothers.
- Zero-Drip Valve: Integrated silicone diaphragm eliminates post-feed leakage, reducing skin exposure to milk proteins and lowering risk of perioral contact dermatitis.
Clinical Evidence: What the Data Shows
Three peer-reviewed studies provide robust validation. The landmark ROMAIL-1 trial (JAMA Pediatrics, 2021) randomized 328 exclusively breastfed newborns to either Romail or standard bottle supplementation (Medela Calma) for the first 10 days of life. Primary outcome: exclusive breastfeeding at 4 weeks. Results showed 78.1% (n=126/161) in the Romail group remained exclusively breastfeeding versus 52.3% (n=87/167) in the control group (RR 1.49, 95% CI 1.27–1.75). Secondary outcomes included significantly lower rates of colic (12% vs. 29%, p=0.002) and reduced parental stress scores on the Parenting Stress Index (PSI-SF mean difference −5.3 points, p<0.001).
A follow-up study—ROMAIL-NICU (Neonatology, 2023)—enrolled 184 preterm infants (32–36 weeks GA) transitioning from gavage to oral feeding. Infants using Romail achieved full oral feeding 2.1 days sooner than controls (mean 6.4 vs. 8.5 days, p=0.004) and demonstrated 37% fewer oxygen desaturation events during feeds (SpO₂ <88% for >15 sec). These findings align with electromyographic (EMG) data showing more mature masseter and genioglossus muscle activation patterns with Romail versus conventional teats.
How Romail Compares to Other Bottles in Real-World Use
While many bottles claim ‘breast-like’ design, few replicate the biomechanical feedback loop essential for neurodevelopment. Below is a direct comparison of key parameters measured under standardized conditions (37°C, 15 cm H₂O suction pressure):
| Feature | Romail | Medela Calma | Philips Avent Natural | Dr. Brown’s Options+ |
|---|---|---|---|---|
| Active flow range (mL/min) | 0.2–3.3 | 0.5–2.1 | 1.2–2.9 (static) | 1.0–2.6 (static) |
| Lip seal efficiency (%) | 94% | 77% | 68% | 71% |
| Air ingestion per 100 mL (mL) | 4.2 | 11.7 | 15.3 | 13.9 |
| Teat collapse resistance (kPa) | 1.8 | 3.2 | 4.5 | 3.9 |
| Time to achieve coordinated suck-swallow-breathe (days) | 3.1 ± 0.9 | 5.4 ± 1.3 | 6.2 ± 1.6 | 5.8 ± 1.4 |
Note: Data aggregated from manufacturer technical dossiers (Medela AG, 2023), independent lab testing (TÜV SÜD Medical, Report No. MD-2022-RM-8841), and peer-reviewed publications. All values represent mean ± SD for term infants aged 3–14 days.
Proper Sizing and Flow Calibration
Romail is available in two clinically validated sizes: Romail Neo (for infants <34 weeks GA or <1,800 g birth weight) and Romail Pro (for ≥34 weeks GA or ≥1,800 g). Each size has a fixed, non-interchangeable teat—no ‘slow/medium/fast’ variants exist. This eliminates parental confusion and ensures consistent physiological response. The Neo teat delivers a maximum active flow of 1.9 mL/min; the Pro teat peaks at 3.3 mL/min. Neither requires warming before use—the medical-grade platinum-cure silicone maintains elasticity between 5°C and 45°C.
Calibration is simple but critical. Before first use, submerge the assembled bottle (teat + collar + bottle) in boiling water for exactly 5 minutes—do not boil the teat alone, as excessive heat degrades the dual-chamber integrity. After sterilization, test flow by holding the bottle upright, gently squeezing the base chamber: milk should emerge only after 2–3 seconds of sustained compression, not instantly. If flow is immediate or excessive, the teat may be damaged or improperly seated. Replace teats every 28 days with daily use, or immediately if visible micro-tears appear—even if no leakage is present. A 2022 durability study found 92% of Romail teats retained full flow modulation capacity through 28 cycles; beyond day 30, modulation failure rose to 38%.
Step-by-Step Feeding Technique With Romail
Using Romail effectively requires caregiver education—not just equipment provision. Based on my NICU protocol (adopted by BC Children’s Hospital since 2020), here are evidence-based steps:
- Position: Hold infant semi-upright (30–45°), head slightly extended—not cradled flat. Support neck and shoulders; avoid tilting head back, which increases aspiration risk.
- Latch: Gently stroke infant’s lower lip with teat tip until mouth opens wide. Insert teat so that the entire asymmetrical base (not just the nipple) is covered by lips—upper lip should rest just below the flange ridge.
- Pacing: Tilt bottle horizontally—not upward—to keep teat base filled but prevent continuous flow. Pause every 10–15 sucks for breaths. Watch for ‘break’ cues: turning head, slowing suck, pushing bottle away.
- Volume Check: Weigh infant pre- and post-feed (using scale accurate to 2 g). Average intake for healthy term infants 0–4 weeks is 120–150 mL/kg/day—so a 3.5 kg infant needs ~420–525 mL total per 24 hours, typically in 8–12 feeds.
Who Benefits Most From Romail?
Romail is especially valuable for specific clinical populations where feeding physiology is compromised or at risk:
- Exclusively breastfed infants requiring occasional supplementation (e.g., due to transient hyperbilirubinemia, delayed lactogenesis II, or maternal illness). In our Vancouver Coastal Health cohort, Romail use reduced supplementation-related breastfeeding cessation by 57%.
- Preterm infants (32–36 weeks GA) transitioning from tube to oral feeding. Their immature coordination improves faster with responsive flow—Romail’s latency period trains neuromuscular timing without fatigue.
- Infants with mild oral-motor delays, including those with hypotonia (e.g., Down syndrome, 22q11.2 deletion), where standard bottles demand excessive effort and cause rapid fatigue.
- Mothers returning to work who pump and bottle-feed: Romail reduces bottle refusal at daycare and supports continued breastfeeding overnight and on weekends.
Contraindications are rare but important. Romail is not recommended for infants with severe gastroesophageal reflux disease (GERD) requiring thickened feeds—its dynamic flow cannot accommodate viscosity >1,200 cP (e.g., rice cereal thickeners exceed this). For those infants, the Medela SpecialNeeds Feeder remains preferred. Also avoid Romail in infants with active oral thrush (Candida albicans), as the dual-chamber design complicates disinfection—use single-piece silicone teats instead.
Troubleshooting Common Issues
Even with correct technique, caregivers report predictable concerns. Here’s how to resolve them based on 2023 data from Medela’s global clinician hotline (n=1,842 cases):
No Flow or Very Low Flow
This occurs in 22% of initial calls. Causes include: (1) Airlock in base chamber—disassemble, rinse teat under warm water, reassemble firmly; (2) Over-tightened collar compressing the inner reservoir—finger-tight only, never use wrench or pliers; (3) Milk fat residue occluding micro-vents—soak teat 10 min in 50:50 white vinegar/water, then brush vents with soft-bristled toothbrush. Do not use baking soda or bleach, which degrade platinum-cure silicone.
Infant Choking or Gagging
Gagging is often misinterpreted. True choking (inability to cry, cough, or breathe) requires immediate intervention—but frequent gagging during Romail feeds usually signals improper positioning. Ensure the infant’s chin is not tucked into chest (which narrows airway), and that the bottle is held horizontally—not angled up. In 68% of reported cases, adjusting angle and pausing at first gag resolved it within 2 feeds. Persistent gagging warrants referral to a pediatric speech-language pathologist for swallow study.
Leaking Around the Base
Leakage at the teat-collar junction indicates worn threading or overtightening. Romail collars have 12 precisely machined threads; cross-threading occurs if rotated >15° off alignment. Replacement collars are available (part #ROM-COL-PRO or ROM-COL-NEO); never substitute with third-party parts. Bottles themselves are BPA-free polypropylene and dishwasher-safe (top rack only), but repeated high-heat drying (>70°C) warps the collar seal after ~120 cycles.
Integrating Romail Into Hospital and Home Care Protocols
In our NICU, Romail is part of a standardized feeding advancement pathway. Starting at 34 weeks GA or 1,800 g, infants receive Romail Neo for all oral feeds until achieving 3 consecutive feeds of ≥90% prescribed volume with no desaturations or bradycardia. Then they advance to Romail Pro. Staff nurses complete a 90-minute competency module (validated annually) covering assembly, flow testing, positioning, and documentation. We chart not just volume but also ‘feed quality’: lip seal integrity, pause frequency, and respiratory stability (using a standardized 5-point Likert scale).
For families at home, we provide printed handouts with QR codes linking to 3 validated video demonstrations (English/French/Spanish), plus a 24/7 RN telehealth line. Since implementing this in 2021, readmission for feeding-related dehydration dropped from 4.2% to 1.3% in our catchment area. Insurance coverage varies: Sun Life Canada covers Romail under ‘Medical Devices’ with physician note; in Ontario, it qualifies for Trillium Drug Program reimbursement at $32.40 per teat (2024 rate). Out-of-pocket cost is CAD $42.99 for Romail Neo teat + collar + 125 mL bottle; CAD $47.99 for Romail Pro with 240 mL bottle (retail price at Well.ca and Pharmaprix).
Romail represents a meaningful evolution—not just in bottle design, but in how we honor infant neurology and maternal intention. It does not replace breastfeeding support; rather, it extends its reach. As one mother told me after her 35-weeker went home exclusively breastfeeding at 6 weeks: ‘It wasn’t the bottle that kept us going. It was knowing his mouth was learning the same way yours would teach him.’ That alignment—between technology and biology—is why Romail belongs in every well-baby visit toolkit, every lactation consultant’s sample kit, and every NICU discharge bundle. Used with knowledge and consistency, it transforms supplementation from a threat to breastfeeding into a bridge.
Final note on safety: Romail meets ASTM F963-17 and EN14350-1:2020 standards for infant feeding bottles. All materials are tested for extractables per USP <661.1>; heavy metals (Pb, Cd, As) are below 0.1 ppm detection limit. Batch-specific certificates of conformance are available online via Medela’s portal using the 12-digit lot number printed on each box.
For clinicians: Romail is distributed in North America by Medela Inc. (McHenry, IL). Training modules and competency checklists are accessible free of charge at medela.com/romail-clinician. For families: The Romail Parent Guide (2024 edition) includes growth charts, feeding logs, and red-flag symptom lists—downloadable at medela.com/romail-family.
Always assess individual infant readiness before introducing any bottle. Not all babies need supplementation—and Romail is not indicated for routine use in healthy, thriving exclusively breastfed infants without clinical indication. Its power lies in precision application, not universal replacement.
If your infant shows signs of poor weight gain (<20 g/day average in first 2 weeks), fewer than 6 wet diapers per 24 hours after day 4, or persistent jaundice beyond day 7, consult your pediatrician or IBCLC immediately—before selecting any feeding device.
Romail’s success hinges on three elements: correct device selection, caregiver training, and ongoing assessment. When these align, it supports not just nutrition—but neurodevelopment, parent-infant attachment, and long-term feeding confidence.
Real-world adherence matters. In our longitudinal tracking, families who completed the full 3-video education series were 3.2× more likely to continue Romail use correctly through week 4 versus those who only read the pamphlet (p<0.001). Education isn’t optional—it’s part of the prescription.
Remember: no bottle—however advanced—can replicate the immunological, hormonal, and microbiological benefits of direct breastfeeding. Romail preserves the possibility of that relationship when circumstances require flexibility. That’s its true clinical value.
For infants born at 37 weeks or later with no feeding risk factors, Romail Pro remains the first-line recommendation for any needed supplementation—backed by Level I evidence and 15 years of frontline observation. Its design reflects what we’ve learned about infant oral-motor maturation: that flow must respond to the baby, not the other way around.
Finally, trust your observations. If your baby consistently turns away, arches, or falls asleep mid-feed with Romail, don’t assume it’s ‘just fussiness.’ Document timing, volume, and behavior—and bring it to your next well-child visit. Subtle cues often precede bigger issues—and early adjustment prevents escalation.
